RyboDyn
Decrypting the dark proteome
San Diego, United States · Founded 2022 · $4.0M raised
- Headquarters
- San Diego
- Employees
- 1–10
- Founded
- 2022
- Website
- rybodyn.com
- Total Funding
- $4.0M
- Last Round
- $4.0M Pre-SeedJan 2025
- Rounds
- 1
About
RyboDyn is a biotechnology company pioneering immunotherapy development by unlocking the dark proteome through its proprietary RyboCypher™ platform, which fuses novel RNA sequencing with AI models to predict proteins encoded by non-coding RNAs. The company transforms these hidden Cryptic Targets™ into antibody-based drug candidates for next-generation cancer immunotherapies.
Summary
RyboDyn is a company based in San Diego, United States, founded in 2022. It has raised $4.0M in total across 1 round, most recently a $4.0M Pre-Seed round in Jan 2025. Investors include Genedant Capital, SeaX Ventures and SOSV.
Tech & App Stack
1 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2025
